Navigation Links
How badger culling creates conditions for spread of bovine TB

A stable social structure may help control the spread of bovine tuberculosis (TB) among badgers, ecologists have found. The findings ?published online in the British Ecological Society's Journal of Animal Ecology ?have important implications for the role of badger culling as part of the strategy to control bovine TB in the UK.

According to the authors from the Central Science Laboratory and the Instituto de Investigación en Recursos Cinegético in Spain: "The evidence suggests that movement of individuals between groups may be instrumental in driving disease dynamics at the population level, and adds further support to the contention that the social disruption of badger populations, for example by culling, is likely to promote disease spread."

Data for the study came from an undisturbed high-density badger population in the Cotswolds, Gloucestershire, that has been intensively studied by ecologists for more than 15 years. The authors analysed almost 9,000 trapping records involving 1,859 different badgers between 1990 and 2004. Each time a badger was trapped it was sexed, weighed and samples of blood, sputum, urine and faeces were taken before it was released. They found that TB rates were lowest when there was the least movement of individual badgers between groups.

There have been few experimental studies of the incidence of infectious disease in socially-structured wildlife populations, and this study shows that such information is crucial to understanding how population structure affects the spread of disease.

The results also have major implications for future policy to control bovine TB in the UK. According to the authors: "Past badger culling policies have been accompanied by an inexorable rise in the incidence of TB in cattle. Indeed, it has become apparent that the various strategies may actually have been a contributory factor to the increase in disease through perturbation. The results presented in this paper lend weigh
'"/>

Source:Blackwell Publishing Ltd.


Page: 1 2

Related biology news :

1. British cattle give TB to badgers, finds UC Davis expert
2. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
3. NIH creates nationwide network of molecular libraries screening centers
4. Purdue creates new low-cost system to detect bacteria
5. Brazil creates buffer zone around coral reefs off Atlantic coast
6. Hopkins scientists show hallucinogen in mushrooms creates universal mystical experience
7. MIT creates 3-D scaffold for growing stem cells
8. Climate change creates dramatic decline in red-winged black bird population
9. Plant genes identified that can form basis for crops better adapted to environmental conditions
10. Life in deadly conditions
11. UF scientists test improved gene therapy method for hereditary heart conditions
Post Your Comments:
Breaking Biology News(10 mins):UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2Princeton scientists find way to catalog all that goes wrong in a cancer cell 2Berkeley Lab researchers participate in Homeland Security study of subway airflow 2Lockheed Martin Expands Health IT Business with 24170 Million in New Health 26amp 3B Human Services Contract Awards 60095 1Lockheed Martin Expands Health IT Business with 24170 Million in New Health 26amp 3B Human Services Contract Awards 60095 2Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 1Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 2Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10
Other Biology Technology:Shire's New Product Portfolio Delivers Strong Quarterly Performance 2Shire's New Product Portfolio Delivers Strong Quarterly Performance 3Shire's New Product Portfolio Delivers Strong Quarterly Performance 4Shire's New Product Portfolio Delivers Strong Quarterly Performance 5Shire's New Product Portfolio Delivers Strong Quarterly Performance 6Shire's New Product Portfolio Delivers Strong Quarterly Performance 7Shire's New Product Portfolio Delivers Strong Quarterly Performance 8Shire's New Product Portfolio Delivers Strong Quarterly Performance 9Shire's New Product Portfolio Delivers Strong Quarterly Performance 10Shire's New Product Portfolio Delivers Strong Quarterly Performance 11Shire's New Product Portfolio Delivers Strong Quarterly Performance 12Shire's New Product Portfolio Delivers Strong Quarterly Performance 13Shire's New Product Portfolio Delivers Strong Quarterly Performance 14Shire's New Product Portfolio Delivers Strong Quarterly Performance 15Shire's New Product Portfolio Delivers Strong Quarterly Performance 16Shire's New Product Portfolio Delivers Strong Quarterly Performance 17Shire's New Product Portfolio Delivers Strong Quarterly Performance 18Shire's New Product Portfolio Delivers Strong Quarterly Performance 19Shire's New Product Portfolio Delivers Strong Quarterly Performance 20Shire's New Product Portfolio Delivers Strong Quarterly Performance 21Shire's New Product Portfolio Delivers Strong Quarterly Performance 22Shire's New Product Portfolio Delivers Strong Quarterly Performance 23Shire's New Product Portfolio Delivers Strong Quarterly Performance 24Shire's New Product Portfolio Delivers Strong Quarterly Performance 25Shire's New Product Portfolio Delivers Strong Quarterly Performance 26Shire's New Product Portfolio Delivers Strong Quarterly Performance 27Shire's New Product Portfolio Delivers Strong Quarterly Performance 28Shire's New Product Portfolio Delivers Strong Quarterly Performance 29Shire's New Product Portfolio Delivers Strong Quarterly Performance 30Shire's New Product Portfolio Delivers Strong Quarterly Performance 31Shire's New Product Portfolio Delivers Strong Quarterly Performance 32Shire's New Product Portfolio Delivers Strong Quarterly Performance 33Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Sinovac to Participate in Two Upcoming Investor Conferences 2